Breaking News Instant updates and real-time market news.

ATXI

Avenue Therapeutics

$4.95

(0.00%)

07:15
06/03/19
06/03
07:15
06/03/19
07:15

Avenue Therapeutics Phase 3 tramadol study achieves primary, secondary endpoints

Avenue Therapeutics announced that its second pivotal Phase 3 trial of IV tramadol achieved the primary endpoint of a statistically significant improvement in sum of pain intensity difference over 24 hours, or SPID24, compared to placebo in patients with postoperative pain following abdominoplasty surgery. In addition, the trial met all of its key secondary endpoints. The study also includes a standard-of-care IV opioid as an active comparator: IV morphine 4 mg. In this study, IV tramadol also demonstrated similar efficacy and safety to that of IV morphine. The Phase 3 multicenter, randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of IV tramadol in 370 patients following abdominoplasty surgery. Patients were randomized in a 3:3:2 ratio to a postoperative regimen of 50 mg of IV tramadol, placebo, or 4 mg of IV morphine at hours 0, 2, 4 and once every 4 hours thereafter, respectively, for up to 13 doses over the course of 48 hours. Morphine, a standard-of-care analgesic, was included to obtain comparative safety data versus IV Tramadol. The primary efficacy endpoint of the study assessed the analgesic efficacy of IV tramadol compared to placebo as measured by SPID24. The key secondary efficacy endpoints included Patient Global Assessment at 24 hours, SPID48, and total consumption of rescue medicine through 24 hours. A key safety objective of the study was to compare the safety and tolerability of IV tramadol to IV morphine. IV tramadol 50 mg achieved the primary endpoint of statistically superior improvement in pain relief as measured by the SPID24 compared to placebo, as well as met all three key secondary endpoints. IV tramadol and IV morphine demonstrated similar efficacy benefits in the study. IV tramadol was well-tolerated with no drug-related serious adverse events in the trial. Most adverse events were mild or moderate with only 2 patients experiencing a Grade 3 event.

  • 19

    Jun

ATXI Avenue Therapeutics
$4.95

(0.00%)

06/25/18
HCWC
06/25/18
INITIATION
Target $11
HCWC
Buy
Avenue Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce initiated Avenue Therapeutics with a Buy rating and $11 price target, stating that its lead candidate, IV Tramadol, would be highly differentiated as the only IV opioid in the U.S. with a DEA Schedule IV if approved.
07/13/18
OPCO
07/13/18
INITIATION
Target $8
OPCO
Outperform
Avenue Therapeutics initiated with an Outperform at Oppenheimer
Oppenheimer analyst Leland Gershell initiated Avenue Therapeutics with an Outperform rating and $8 price target, telling investors that Avenue is an "under-recognized story" whose fundamentals belie its sub-$50M market cap. He believes the stock is very attractive at current levels, despite the next significant milestone being about a year away, and recommends investors use this opportunity to build a position.

TODAY'S FREE FLY STORIES

AKAM

Akamai

$91.72

0.15 (0.16%)

13:35
10/21/19
10/21
13:35
10/21/19
13:35
Hot Stocks
Akamai says peak traffic on Akamai intelligent edge platform exceeds 100 Tbps »

Akamai announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Nov

  • 09

    Dec

VRTX

Vertex

$176.23

-0.01 (-0.01%)

13:29
10/21/19
10/21
13:29
10/21/19
13:29
Hot Stocks
Vertex says Spanish government approves national reimbursement of CF combos »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

STRM

Streamline Health

$1.20

0.02 (1.69%)

, AGO

Assured Guaranty

$47.16

0.28 (0.60%)

13:19
10/21/19
10/21
13:19
10/21/19
13:19
On The Fly
Fly Insider: Streamline, Proofpoint among week's notable insider trades »

Welcome to "Fly Insider,"…

STRM

Streamline Health

$1.20

0.02 (1.69%)

AGO

Assured Guaranty

$47.16

0.28 (0.60%)

TAYD

Taylor Devices

$10.72

0.21 (2.00%)

CMCT

CIM Commercial Trust

$14.70

0.1 (0.68%)

ATNX

Athenex

$9.81

-0.39 (-3.82%)

OKTA

Okta

$101.00

2.32 (2.35%)

LRCX

Lam Research

$239.22

5.56 (2.38%)

FISV

Fiserv

$104.30

-1.41 (-1.33%)

PFPT

Proofpoint

$120.13

0.7 (0.59%)

ANET

Arista Networks

$245.27

5.57 (2.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 31

    Oct

  • 05

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

  • 12

    Dec

  • 16

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/21/19
10/21
13:17
10/21/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/21/19
10/21
13:16
10/21/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRM

Iron Mountain

$33.96

0.44 (1.31%)

13:15
10/21/19
10/21
13:15
10/21/19
13:15
Options
Iron Mountain put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 12

    Nov

BA

Boeing

$333.70

-10.39 (-3.02%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Periodicals
Boeing CEO cites 'steady progress' on 737 MAX in internal email, Reuters says »

Boeing's CEO said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FTCH

Farfetch

$8.18

0.15 (1.87%)

13:05
10/21/19
10/21
13:05
10/21/19
13:05
Options
Farfetch Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

13:04
10/21/19
10/21
13:04
10/21/19
13:04
Periodicals
POTUS says trade pact with China coming along great, Reuters says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$299.80

1.815 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$118.45

0.96 (0.82%)

, MCD

McDonald's

$209.91

1.43 (0.69%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$118.45

0.96 (0.82%)

MCD

McDonald's

$209.91

1.43 (0.69%)

UTX

United Technologies

$138.27

1.42 (1.04%)

NEE

NextEra Energy

$231.47

-1.21 (-0.52%)

LMT

Lockheed Martin

$373.98

1.36 (0.36%)

UPS

UPS

$119.05

1.72 (1.47%)

SHW

Sherwin-Williams

$559.43

-1.54 (-0.27%)

KMB

Kimberly-Clark

$138.03

0.73 (0.53%)

BIIB

Biogen

$224.66

4.61 (2.10%)

TRV

Travelers

$141.76

0.32 (0.23%)

PCAR

Paccar

$73.44

1.39 (1.93%)

FITB

Fifth Third

$27.91

0.575 (2.10%)

CNC

Centene

$46.98

0.06 (0.13%)

RF

Regions Financial

$16.08

0.3 (1.90%)

NUE

Nucor

$52.25

0.56 (1.08%)

HAS

Hasbro

$120.60

-1.29 (-1.06%)

TRU

TransUnion

$82.01

0.52 (0.64%)

DGX

Quest Diagnostics

$102.55

-0.12 (-0.12%)

IPG

Interpublic Group

$20.69

0.04 (0.19%)

HOG

Harley-Davidson

$37.11

0.53 (1.45%)

PII

Polaris Industries

$92.01

1.395 (1.54%)

SNV

Synovus

$36.36

1.07 (3.03%)

JBLU

JetBlue

$17.63

0.675 (3.98%)

GPK

Graphic Packaging

$15.01

0.355 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 19

    Nov

  • 04

    Dec

  • 07

    Dec

BMRN

BioMarin

$68.98

-0.18 (-0.26%)

13:03
10/21/19
10/21
13:03
10/21/19
13:03
Hot Stocks
BioMarin treatment of phenylketonuria granted FDA orphan status »

BioMarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 23

    Oct

  • 07

    Dec

UPS

UPS

$119.07

1.74 (1.48%)

, FDX

FedEx

$153.86

3.97 (2.65%)

13:00
10/21/19
10/21
13:00
10/21/19
13:00
Earnings
Fly Intel: What to watch in UPS earnings report »

UPS (UPS) is scheduled to…

UPS

UPS

$119.07

1.74 (1.48%)

FDX

FedEx

$153.86

3.97 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

, CDNS

Cadence Design

$66.73

1.13 (1.72%)

12:59
10/21/19
10/21
12:59
10/21/19
12:59
Earnings
Notable companies reporting after market close »

Notable companies…

AMTD

TD Ameritrade

$37.85

1.06 (2.88%)

CDNS

Cadence Design

$66.73

1.13 (1.72%)

CE

Celanese

$122.11

0.44 (0.36%)

ZION

Zions Bancorp

$45.40

0.68 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 06

    Nov

  • 19

    Nov

EL

Estee Lauder

$186.09

0.44 (0.24%)

12:56
10/21/19
10/21
12:56
10/21/19
12:56
Downgrade
Estee Lauder rating change  »

Estee Lauder downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 15

    Nov

12:50
10/21/19
10/21
12:50
10/21/19
12:50
General news
Treasury's agenda for the November refunding meeting wanted dealer insights »

Treasury's agenda…

FB

Facebook

$189.22

3.265 (1.76%)

12:49
10/21/19
10/21
12:49
10/21/19
12:49
Hot Stocks
Facebook updates inauthentic behavior policy to counter new tactics »

Facebook said in a post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

FB

Facebook

$189.22

3.265 (1.76%)

12:48
10/21/19
10/21
12:48
10/21/19
12:48
Hot Stocks
Facebook launches 'Protect' to secure accounts of elected officials »

Facebook announced on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

OPOF

Old Point Financial

$24.61

(0.00%)

12:46
10/21/19
10/21
12:46
10/21/19
12:46
Hot Stocks
Old Point Financial appoints Elizabeth Beale CFO »

Elizabeth Beale has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$19.72

0.16 (0.82%)

12:45
10/21/19
10/21
12:45
10/21/19
12:45
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 13

    Nov

INFO

IHS Markit

$69.67

-0.08 (-0.11%)

12:41
10/21/19
10/21
12:41
10/21/19
12:41
Conference/Events
IHS Markit management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

MSFT

Microsoft

$137.79

0.45 (0.33%)

12:36
10/21/19
10/21
12:36
10/21/19
12:36
Hot Stocks
Microsoft acquires cloud file migration provider Mover; terms not disclosed »

Jeff Teper, CVP Office,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

DEST

Destination Maternity

$0.20

-0.136 (-40.48%)

12:27
10/21/19
10/21
12:27
10/21/19
12:27
Periodicals
Destination Maternity plans bankruptcy filing in next few weeks, CNBC reports »

Destination Maternity is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$39.14

0.305 (0.79%)

12:25
10/21/19
10/21
12:25
10/21/19
12:25
Options
PagSeguro Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

GSK

GlaxoSmithKline

$42.46

-0.06 (-0.14%)

12:20
10/21/19
10/21
12:20
10/21/19
12:20
Hot Stocks
GlaxoSmithKline to divest rabies, tick-borne encephalitis vaccines »

GlaxoSmithKline announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

  • 07

    Dec

12:20
10/21/19
10/21
12:20
10/21/19
12:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.